Brieffda Approves Sglt2 Inhibitor Steglatro And Fixeddose Combination Steglujan For Adults With Type 2 Diabetes | Latest News RSS feed

Brieffda Approves Sglt2 Inhibitor Steglatro And Fixeddose Combination Steglujan For Adults With Type 2 Diabetes - Latest News


BRIEF-FDA Approves SGLT2 Inhibitor Steglatro And Fixed-Dose Combination Steglujan For Adults With Type 2 Diabetes

Dec 22 (Reuters) - Merck & Co Inc: * FDA APPROVES SGLT2 INHIBITOR STEGLATRO™ (ERTUGLIFLOZIN) AND FIXED-DOSE COMBINATION STEGLUJAN™ (ERTUGLIFLOZIN AND SITAGLIPTIN) FOR ADULTS WITH TYPE 2 DIABETES * MER... read more

Merck, Pfizer: FDA Approves Steglatro And Fixed-dose Combination Steglujan

Merck & Co. Inc. (MRK) and Pfizer Inc. (PFE) said that the U.S. Food and Drug Administration has approved Steglatro (ertugliflozin) tablets, an oral sodium-glucose cotransporter 2 or SGLT2 inhibitor, ... read more

Merck Announces Fourth-Quarter and Full-Year 2017 Financial Results

Merck and Pfizer announced that the FDA approved STEGLATRO (ertugliflozin) tablets, an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor, the fixed-dose combination STEGLUJAN ... glycemic control ... read more

Looking for another news?


PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2017 RESULTS

The 2018 financial guidance for the effective tax rate on Adjusted income (2) reflects the enactment of the TCJA. Financial guidance for Adjusted diluted EPS (2) anticipates share repurchases totaling ... read more


Merck and : - FDA APPROVES SGLT2 INHIBITOR STEGLATRO AND FIXED-DOSE COMBINATION STEGLUJAN FOR ADULTS WITH TYPE 2 DIABETES

an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor, and the fixed-dose combination STEGLUJAN (ertugliflozin and sitagliptin) tablets. STEGLATRO is indicated as an adjunct to diet and exercise to ... read more

BRIEF-Party City Announces Repurchase Of Common Stock

Dec 22 (Reuters) - Party City Holdco Inc: * PARTY CITY ANNOUNCES REPURCHASE OF COMMON STOCK * PARTY CITY HOLDCO INC - PURCHASE OF 19.8 MILLION SHARES OF COMMON STOCK FOR $242 MILLION FROM ADVENT-PARTY ... read more

PFIZER : REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS

The 2018 financial guidance for the effective tax rate on Adjusted income (2) reflects the enactment of the TCJA. Financial guidance for Adjusted diluted EPS (2) anticipates share repurchases totaling ... read more

PFIZER REPORTS FIRST-QUARTER 2018 RESULTS

2018 FINANCIAL GUIDANCE (5) Pfizer’s reaffirmed 2018 financial guidance is presented below. Financial guidance for Adjusted diluted EPS (2) now anticipates share repurchases totaling approximately $6. ... read more

BRIEF-Qualcomm Board Rejects Director Nominees Assembled By Broadcom, Silver Lake Partners (QCOM, AVGO)

Dec 22 (Reuters) - Qualcomm Inc: * QUALCOMM BOARD UNANIMOUSLY REJECTS DIRECTOR NOMINEES ASSEMBLED BY BROADCOM AND SILVER LAKE PARTNERS * QUALCOMM - FOLLOWING RECOMMENDATION OF BOARD'S GOVERNANCE COMMI... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us